Candida haemulonii complex (Candida haemulonii [I], Candida duobushaemulonii [II], and Candida haemulonii var. vulnera [III]) has become relevant in recent times, not so much because of a high incidence in human clinical sample cultures but because of its remarkable antifungal resistance. The objective of this study was to evaluate several methods for the identification of this uncommon species of Candida. Ten isolates of C. haemulonii were identified by biochemical and proteomic methods, and their antifungal susceptibility testing was performed by both commercial and reference methods. MALDI-TOF MS (Vitek MS and Vitek MS PRIME) and Vitek2 correctly identified these genera but API method did not. There was a good correlation between the commercial methods and the reference methods for the AST. In conclusion Vitek MS, Vitek MS PRIME, and Vitek2 systems, but not API32C, are reliable for identification of C. haemulonii complex. Furthermore, MALDI-TOF MS systems could identify to the subspecies level. Commercial methods for antifungal susceptibility testing are valid for the study of this species and confirm amphotericin B and to azole resistance.

Department of Molecular Biology University of Cantabria Santander Spain

Microbiology Service University Hospital Marqués de Valdecilla IDIVAL CIBERINFEC Avda Valdecilla s n CP 39008 Santander Spain

Zobrazit více v PubMed

Ben-Ami R, Berman J, Novikov A, Bash E, Shachor-Meyouhas Y, Zakin S et al (2017) Multidrug-resistant Candida haemulonii and C. auris, Tel Aviv. Israel Emerg Infect Dis 23:195–203. https://doi.org/10.3201/eid2302.161486 PubMed DOI

Cendejas-Bueno E, Kolecka A, Alastruey-Izquierdo A, Theelen B, Groenewald M, Kostrzewa M et al (2012) Reclassification of the Candida haemulonii complex as Candida haemulonii (C. haemulonii Group I), C. duobushaemulonii sp. nov. (C. haemulonii Group II), and C. haemulonii var. vulnera var. nov.: three multiresistant human pathogenic yeasts. J Clin Microbiol 50:3641–3651. https://doi.org/10.1128/JCM.02248-12 PubMed DOI PMC

Coles M, Cox K, Chao A (2020) Candida haemulonii: an emerging opportunistic pathogen in the United States? Idcases 21

De jong AW, Al-Obaid K, Mohd Tap R, Gerrits van den Ende B, Groenewald M, Joseph L et al (2023) Candida khanbhai sp. nov., a new clinically relevant yeast within the Candida haemulonii species complex. Med Mycol 61:1–2. https://doi.org/10.1093/mmy/myad009 DOI

Fang SY, Wei KC, Chen WC, Lee SJ, Yang KC, Wu CS et al (2016) Primary deep cutaneous candidiasis caused by Candida duobushaemulonii in a 68-year-old man: the first case report and literature review. Mycoses 59:818–821. https://doi.org/10.1111/myc.12540

Gargeya IB, Pruitt WR, Meyer SA, Ahearn DG (1991) Candida haemulonii from clinical specimens in the USA. J Med Vet Mycol 29:335–338 PubMed DOI

Giusiano G, Magianterra M, Garcia Saito V, Rojas F, Gómez V, Días MC (2006) Fluconazole and itraconazole resistance of yeasts isolated from the bloodstream and catheters of hospitalized pediatric patients. Chemotherapy 52:254–259. https://doi.org/10.1159/000094867 PubMed DOI

Grenfell RC, da Silva Junior AR, Del Negro GM, Munhoz RB, Gimenes VM, Assis DM et al (2016) Identification of Candida haemulonii complex species: use of ClinProTools

Gutierrez J, Martín E, Lozano C, Coronilla J, Nogales C (1994) Evaluation of the ATB 32C, automicrobic system and API 20C using clinical yeast isolates. Ann Biol Clin 50:443–446

Hou X, Xiao M, Chen SC, Wang H, Cheng JW, Chen XX et al (2016) Identification and antifungal susceptibility profiles of Candida haemulonii species complex clinical isolates from a multicenter study in China. J Clin Microbiol 54:2676–2680. https://doi.org/10.1128/JCM.01492-16

Kathuria S, Singh PK, Sharma C, Prakash A, Masih A, Kumar A et al (2015) Multidrug-resistant Candida auris misidentified as Candida haemulonii: characterization by matrix-assisted laser desorption ionization-time of flight mass spectrometry and DNA sequencing and its antifungal susceptibility profile variability by Vitek2, CLSI broth microdilution, and Etest method. J Clin Microbiol 53:1823–1830. https://doi.org/10.1128/JCM.00367-15 PubMed DOI PMC

Kim MN, Shin JH, Sung H, Lee K, Kim EC, Ryoo N et al (2009) Candida haemulonii and closely related species at 5 University Hospitals in Korea: identification, antifungal susceptibility, and clinical features. Clin Infect Dis 48:e57–e61. https://doi.org/10.1086/597108

Kim S, Ko KS, Moon SY, Lee MS, Lee MY, Son JS (2011) Catheter-related candidemia caused by Candida haemulonii in a patient in long-term hospital care. J Korean Med Sci 26:297–300. https://doi.org/10.3346/jkms.2011.26.2.297 PubMed DOI PMC

Kordalewska M, Zhao Y, Lockhart SR, Chowdhary A, Berrio I, Perlin DS (2017) Rapid and accurate molecular identification of the emerging multidrug-resistant pathogen Candida auris. J Clin Microbiol 55:2445–2452. https://doi.org/10.1128/JCM.00630-17 PubMed DOI PMC

Kurtzman CP, Robnett CJ (1997) Identification of clinically important ascomycetous yeasts based on nucleotide divergence in the 5′ end of the large-subunit (26S) ribosomal DNA gene. J Clin Microbiol 35:1216–1223. https://doi.org/10.1128/jcm.35.5.1216-1223.1997 PubMed DOI PMC

Lavarde V, Daniel F, Saez H, Arnold M, Faguer B (1984) Peritonite mycosique a Torulopsis haemulonii. Bul Soc Fr Mycol Med 13:173–176

Lehmann PF, Wu LC, Pruitt WR, Meyer SA, Ahearn DG (1993) Unrelatedness of groups of yeasts within the Candida haemulonii complex. J Clin Microbiol 31:1683–1687. https://doi.org/10.1128/jcm.31.7.1683-1687.1993 PubMed DOI PMC

Loosova G, Jindrak L, Kopacek P (2001) Mortality caused by experimental infection with the yeast Candida haemulonii in the adults of Ornithodoros moubata (Acarina: Argasidae). Folia Parasitol 48:149–153. https://doi.org/10.14411/fp.2001.023 DOI

Marathe A, Zhu Y, Chaturvedi V, Chaturvedi S (2022) Utility of CHROMagar

Mizusawa M, Miller H, Green R, Lee R, Durante M, Perkins R et al (2017) Can Multidrug-resistant Candida auris be reliably identified in clinical microbiology laboratories? J Clin Microbiol 55:638–640. https://doi.org/10.1128/JCM.02202-16 PubMed DOI PMC

Muro MD, Motta Fde A, Burger M, Melo AS, Dalla-Costa LM (2012) Echinocandin resistance in two Candida haemulonii isolates from pediatric patients. J Clin Microbiol 50:3783–3785. https://doi.org/10.1128/JCM.01136-12 PubMed DOI

Ramos LS, Figueiredo-Carvalho MH, Barbedo LS, Ziccardi M, Chaves AL, Zancopé-Oliveira RM et al (2015) Candida haemulonii complex: species identification and antifungal susceptibility profiles of clinical isolates from Brazil. J Antimicrob Chemother 70:111–115. https://doi.org/10.1093/jac/dku321

Satoh K, Makimura K, Hasumi Y, Nishiyama Y, Uchida K, Yamaguchi H (2009) Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol 53:41–44. https://doi.org/10.1111/j.1348-0421.2008.00083.x PubMed DOI

Shin JH, Kim MN, Jang SJ, Ju MY, Kim SH, Shin MG et al (2012) Detection of Amphotericin B resistance in Candida haemulonii and closely related species by use of the Etest, Vitek-2 yeast susceptibility system, and CLSI and EUCAST broth microdilution methods. J Clin Microbiol 50:1852–1855. https://doi.org/10.1128/JCM.06440-11 PubMed DOI PMC

Silva LN, Ramos LS, Oliveira SSC, Magalhães LB, Squizani ED, Kmetzsch L et al (2020) Insights into the multi-azole resistance profile in Candida haemulonii species complex. J Fungi (basel) 6:215. https://doi.org/10.3390/jof6040215 PubMed DOI

Sugita T, Takashima M, Poonwan N, Mekha N (2006) Candida pseudohaemulonii sp. nov., an amphotericin B- and azole-resistant yeast species, isolated from the blood of a patient from Thailand. Microbiol Immunol 50:469–473. https://doi.org/10.1111/j.1348-0421.2006.tb03816.x PubMed DOI

Van Uden K, Kolipinski MC (1962) Torulopsis haemulonii nov. spec., a yeast from the Atlantic Ocean. Antonie Van Leeuwenhoek 28:78–80. https://doi.org/10.1007/BF02538724 PubMed DOI

Verweij PE, Breuker IM, Rijs AJ, Meis JF (1999) Comparative study of seven commercial yeast identification systems. J Clin Pathol 52:271–273. https://doi.org/10.1136/jcp.52.4.271 PubMed DOI PMC

White TJ, Innis MA, Gelfand DH, Sninsky J (1990) PCR protocols, a guide to methods and applications. Academic Press N.Y.315–322

Xia FQ, Ye CY, Xie WW, Poont ND, Zhou YH (2018) Successful fluconazole treatment of catheter-related candidemia caused by Candida haemulonii: report of 2 neonatal cases. Arch Argent Pediatr 116:e663–e666. https://doi.org/10.5546/aap.2018.eng.e663 PubMed DOI

Yarrow D, Meyer SA (1978) Proposal for amendment of the diagnosis of the genus Candida Berkhout nom. Cons Int J Syst Bacteriol 98:611–615 DOI